期刊文献+

特发性扩张型心肌病合并甲状腺功能减退加重心肌损伤的影像学评价 被引量:7

Myocardial injury aggravated by hypothyroidism in patients with idiopathic dilated cardiomyopathy: the evidence based on ^99Tc^m-MIBI SPECT/^18F-FDG PET imaging and cardiac MRI
原文传递
导出
摘要 目的通过^99Tcm-MIBI心肌灌注SPECT/^18F—FDG心肌代谢PET显像和心脏MRI延迟增强成像(cMRI—LGE),探讨特发性扩张型心肌病(IDC)合并甲状腺功能减退(简称甲减)与心肌损伤的关系。方法2010年10月至2012年12月诊断为IDC的连续病例63例[男42例,女21例,平均年龄(52±11)岁]入选,患者均进行血浆TT3、TT4、FT3、FT4和TSH全自动化学发光免疫法测定、^99Tcm-MIBI心肌灌注SPECT/^18F—FDG心肌代谢PET显像和cMRI—LGE。利用标准17节段模型进行心肌节段分析,灌注/代谢图像分成4种类型:正常灌注/代谢、灌注/代谢不匹配、灌注/代谢轻中度匹配、灌注/代谢完全匹配;cMRI-LGE图像分为无延迟强化、壁间强化和透壁强化。通过x^2检验进行分组数据的比较。结果根据所测血浆激素水平,患者被分成甲状腺功能(简称甲功)正常组(53例)和甲减组(10例)。甲功正常组正常灌注/代谢的心肌节段数所占的比例明显高于甲减组:71.8%(647/901)和57.6%(98/170),x^2=13.50,P〈0.001;而灌注/代谢不匹配的心肌节段比例则低于甲减组:17.8%(160/901)和31.2%(53/170)x^2=16.20,P〈0.001。甲功正常组cMRI—LGE无延迟强化的心肌节段比例明显高于甲减组,分别为88.0%(793/901)和69.4%(118/170),x^2=35.70,P〈0.001;但壁间强化的心肌节段比例则低于甲减组,分别为4.8%(43/901)和24.1%(41/170),x^2=74.70,P〈0.001。结论^99Tc^m-MIBI心肌灌注SPECT/^18F—FDG心肌代谢PET显像和cMRI—LGE证实甲减能够加重IDC患者的心肌损伤。SPECT/PET可以检测出更多的慢性缺血/存活心肌,而cMRI-LGE可以检测出更多的心肌纤维化病变,两者结合能提供更全面的心肌损伤信息。 Objective To explore the relationship between hypothyroidism and myocardial injury in patients with idiopathic dilated cardiomyopathy (IDC) by ^99Tcm-MIBI SPECT/^18F-FDG PET and late-gadolinium enhancement cardiac magnetic resonance imaging (cMRI-LGE). Methods Sixty-three consecutive patients (42 males and 21 females, (52±11) years) with IDC were enrolled from October 2010 to December 2012. Serum TT3, TF4, FT3, FT4 and TSH were determined using a fully automated chemiluminescence immunoassay. All patients underwent ^99Tcm-MIBI myocardial perfusion SPECT/^18F-FDG myocardial metabolism PET imaging and cMRI-LGE. Seventeen segments model was used for segmental analysis. Patterns ofperfusion/metabolism were classified as normal, mismatch, mild-to-moderate match and complete match. cMRI-LGE was classified into 3 categories (non-LGE, mid-wall LGE and transmural LGE). x^2 test was used for data analysis. Results All patients were divided into euthyroid group (n = 53) and hypothyroidism group (n= 10) according to the levels of serum thyroid hormones. The percentage of normal perfusion/metabolism segments in the euthyroid group was apparently higher than that in the hypothyroidism group: 71.8% (647/901) vs 57.6% (98/170), x^2= 13.50, P〈0.001 ; whereas the percentage of perfusion/metabolism mismatch segments in the euthyroid group was significantly lower than that in the hypothyroidism group: 17.8%(160/901) vs 31.2%(53/170), x^2= 16.20, P〈0.001. The euthyroid group had a higher percentage of non-LGE segments (88.0% (793/901) vs 69.4% ( 118/170), x^2 = 35.70, P〈0.001 ) and a lower percentage of mid-wall LGE segments (4.8% (43/901) vs 24.1% (41/170), x^2 = 74.70, P〈0.001 ) compared to hypothyroidism group. Conclusions Hypothyroidism has a detrimental effect on myocardium. ^99Tcm-MIBI SPECT/^18F-FDG PET imaging is sensitive in detecting viable/isehemia myocardium, and cMRI-LGE is good at detecting moderate fibrosis. Combining SPECT/PET imaging and cMRI-LGE for assessing myocardial iniury would provide more comprehensive information.
出处 《中华核医学与分子影像杂志》 CSCD 北大核心 2014年第3期161-165,共5页 Chinese Journal of Nuclear Medicine and Molecular Imaging
关键词 心肌病 充血性 甲状腺功能减退症 体层摄影术 发射型计算机 体层摄影术 X线 计算机 磁共振成像 MIBI Cardiomyopathy, congestive Hypothyroidism Tomography, emission-computed Tomography, X-ray computed Magnetic resonance imaging MIBI
  • 相关文献

参考文献21

  • 1Fazio S, Palmierl EA, Lombardi G, et al. Effects of thyroid hor- mone on the cardiovascular system [ J ]. Recent Preg Horm Res, 2004, 59: 31-50.
  • 2Klein I, Danzi S. Thyroid disease and the heart[J]. Circulation, 2007, 116: 1725-1735.
  • 3Tribulova N, Knezl V, Shainberg A, et al. Thyroid hormones and cardiac arrhythmias[J]. Vascul Pharmacol, 2010, 52: 102-112.
  • 4Kahaly GJ, Dillmann WH. Thyroid hormone action in the heart[J]. Endocr Rev, 2005, 26: 704-728.
  • 5Wu Y, Koenig RJ. Gene regulation by thyroid hormone[ J]. Trends Endoerinol Metab, 2000, 11 : 207-211.
  • 6Inoue A, Fujimoto S, Yamashina S, et al. Prediction of cardiac events in patients with dilated cardiomyopathy using ^123I-BMIPP and ^201T1 myocardial scintigraphy[ J ]. Ann Nucl Med, 2007, 21 : 399-404.
  • 7Khochtali I, Hamza N, Harzallah O, et al. Reversible dilated car- diomyopathy caused by hypothyroidism [ J ]. Int Arch Med, 2011, 4: 20.
  • 8Kota SK, Tripathy PR, Kota SK, et al. Primary hypothyroidism: uncommon presentation with reversible dilated cardiomyopathy in a young subject[J]. Int J Endocfinol Metab, 2012, 10: 440-443.
  • 9Tang YD, Kuzman JA, Said S, et al. Low thyroid function leads to car- diac atrophy with chamber dilatation, impaired myocardial blood flow, loss of arterioles, and severe systolic dysfunction[ J]. Circulation, 2005, 112: 3122-3130.
  • 10Khalife WI, Tang YD, Kuzman JA, et al. Treatment of subclinical hypothyroidism reverses ischemia and prevents myocyte loss and progressive LV dysfunction in hamsters with dilated cardiomyopathy [J]. Am J Physiol Heart Circ Physiol, 2005, 289: H2409-2415.

二级参考文献24

  • 1Fatkin D, Otway R, Richmond Z. Genetics of dilated cardiomyop- athy. Heart Fail Clin, 2010, 6: 129-140.
  • 2Wexler RK, Elton T, Pleister A, et al. Cardiomyopathy: an over- view. Am Fam Physician, 2009 : 778-784.
  • 3Jefferies JL, Towbin JA. Dilated cardiomyopathy. Lancet, 2010, 375 : 752-762.
  • 4Neglia D, L'Abbate A. Coronary microvascular dysfunction and id- iopathic dilated cardiomyopathy. Phannacol Rep, 2005,57 Suppl : 151-155.
  • 5West AM, Kramer CM. Cardiovascular magnetic resonance imaging of myocardial infarction, viability, and cardiomyopathies. Curr Probl Cardiol, 2010, 35: 176-220.
  • 6de Jong RM, Tio RA, van der Harst P, et al. Ischemic patterns assessed by positron emission tomoaphy predict adverse outcome in patients with idiopathic dilated cardiomyopathy. J Nucl Cardiol, 2009, 16: 769-774.
  • 7Ono H, Funabashi N, Uehara M, et al. Comprehensive evaluation of characteristics of left ventricular myocardium in a subject with non-coronary arterial cardiac dysfunction through segment by seg- ment analysis using various diagnostic modalities. Int J Cardiol, 2010, 145: 95-100.
  • 8Maron BJ', Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Out- comes Research and Functional Genomics and Translational BiologyInterdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation, 2006, 113 : 1807-1816.
  • 9Wang F, Zhang J, Fang W, et al. Evaluation of left ventricular vol- umes and ejection fraction by gated SPECT and cardiac MRI in pa- tients with dilated cardiomyopathy. Eur J Nucl Med Mol Imaging, 2009, 36: 1611-1621.
  • 10Liu Q, Zhao S, Yan C, et al. Myocardial viability in chronic is- chemic heart disease : comparison of delayed-enhancement magnetic resonance imaging with 99 Tcm.sestamibi and is F-fluorodeoxyglucose single-photon emission computed tomography. Nucl Med Commun, 2009, 30: 610-616.

共引文献1

同被引文献60

引证文献7

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部